임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
58건 표시
- 2상모집 중· Anatomic Stage IV Breast Cancer AJCC v8177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
협력: 노바티스
- 2상모집 중· Primary Immune Thrombocytopenia (ITP)A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
리드: 노바티스
- 2상모집 중· Primary Immune ThrombocytopeniaStudy of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
리드: 노바티스
- 2상모집 중· Liver Cancer68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
협력: 노바티스
- 2상모집 중· Hypertension (HTN)An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
리드: 노바티스
- 2상모집 중· Chronic Myelogenous LeukemiaStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
리드: 노바티스
- 2상모집 중· Immunoglobulin A Nephropathy (IgAN)A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
리드: 노바티스
- 2상모집 중· Non-segmental VitiligoA Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
리드: 노바티스
- 2상모집 중· Geographic Atrophy Secondary to Age-related Macular DegenerationA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
리드: 노바티스
- 2상모집 중· Oligometastatic Prostate AdenocarcinomaAlpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma
협력: 노바티스
- 2상모집 중· CryptosporidiosisStudy Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
리드: 노바티스
- 2상모집 중· PIK3CA-related Overgrowth Spectrum (PROS)EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
리드: 노바티스
- 2상모집 중· Alzheimer's DiseaseA Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
리드: 노바티스
- 2상모집 중· HER2 Negative Breast CancerImpact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
협력: 노바티스
- 2상모집 중· Metastatic Hormone-sensitive Prostate CancerAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
리드: 노바티스
- 2상모집 중· Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
리드: 노바티스
- 2상모집 중· Metastatic Castration-Resistant Prostate CarcinomaLow PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
협력: 노바티스
- 2상모집 중· Chagas DiseaseA Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
리드: 노바티스
- 2상모집 중· ANCA Associated Vasculitis (AAV)Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
리드: 노바티스
- 2상모집 중· Prostate AdenocarcinomaNeoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
협력: 노바티스
- 2상모집 중· Glomerulonephritis, IGAStudy to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
리드: 노바티스
- 2상모집 중· Chronic Myeloid Leukemia (CML)Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
리드: 노바티스
- 2상모집 중· Malignant Solid TumorsPhase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
협력: 노바티스
- 2상모집 중· Scleroderma, DiffusePhase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
리드: 노바티스
- 2상모집 중· Diffuse Cutaneous Systemic SclerosisA Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
리드: 노바티스
- 2상모집 중· Castration-Resistant Prostate CarcinomaVorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
협력: 노바티스
- 2상모집 중· Lupus Erythematosus, SystemicA Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
리드: 노바티스
- 2상모집 중· High Grade GliomaStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
협력: 노바티스
- 2상모집 중· Castration-Resistant Prostate CarcinomaRe-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
협력: 노바티스
- 2상모집 중· Neuroendocrine Tumors177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
협력: 노바티스
- 2상모집 중· Chronic Myeloid LeukemiaPhase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
협력: 노바티스
- 2상모집 중· Uncomplicated Plasmodium Falciparum MalariaPlatform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
리드: 노바티스
- 2상모집 중· CraniopharyngiomaTreatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
협력: 노바티스
- 2상모집 중· HER2-negative Breast CancerAlpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
협력: 노바티스
- 2상모집 중· Anaplastic Thyroid CancerNEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)
협력: 노바티스
- 2상모집 중· Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)
협력: 노바티스
- 2상모집 중· Lupus NephritisStudy of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
리드: 노바티스
- 2상모집 중· Squamous Cell Anal CarcinomaCombination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma
협력: 노바티스
- 2상모집 중· Neuroblastoma Recurrent177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
협력: 노바티스
- 2상모집 중· CancerThe Drug Rediscovery Protocol (DRUP Trial)
협력: 암젠, 아스트라제네카, BMS, GSK, 일라이 릴리, 머크(MSD), 노바티스, 화이자
- 2상모집 중· Lymphoma, Non-HodgkinTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
협력: 아스트라제네카, BMS, 일라이 릴리, 노바티스, 화이자, 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.